M edical device company Globus Medical (NYSE:GMED) reported Q4 CY2024 results , with sales up 6.6% year on year to $657.3 million. The company expects the full year’s revenue to be around $2.68 ...

Following the consummation of the Nevro, Inc. acquisition, which we expect to close in the late second quarter of 2025, Globus Medical anticipates 2025 net sales of $2.80 billion to $2.90 billion ...

Globus Medical Trading Up 0.8 % Shares of Globus Medical stock opened at $76.65 on Wednesday. Globus Medical, Inc. has a 52 week low of $49.33 and a 52 week high of $94.93. The stock has a market ...

This surpassed our model’s projection of $511.8 million in sales from this region. Globus Medical, Inc. Price, Consensus and EPS Surprise Globus Medical, Inc. Price, Consensus and EPS Surprise ...

Learn more about whether Globus Medical, Inc. or Lantheus Holdings, Inc. is a better investment based on AAII's A+ Investor ...

Envestnet Portfolio Solutions Inc. lifted its stake in shares of Globus Medical, Inc. (NYSE:GMED – Free Report) by 3.0% ...

Globus Medical, Inc. GMED continues to benefit from ... In the fourth quarter, Globus' musculoskeletal sales improved 4.5% year over year. The growth was driven primarily by strong contributions ...

Learn more about whether Globus Medical, Inc. or QuidelOrtho Corporation is a better investment based on AAII's A+ Investor ...